drugset / Trial / NCT02553603
The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is examining the effects of growth hormone releasing hormone (GHRH) on mild cognitive impairment (MCI). GHRH will be given at a dose of 1mg/day for 10 weeks to subjects with MCI as well as healthy controls.
Timeline
- Start
- 2017-07-18
- Primary completion
- 2019-01-17
- Completion
- 2019-01-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tesamorelin | Peptide | 1 mg | — |